Janus Henderson Group’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
16,500
+8,100
+96% +$469K ﹤0.01% 1541
2025
Q4
$346K Buy
+8,400
New +$326K ﹤0.01% 2152
2025
Q2
Sell
-683,616
Closed -$13.7M 2429
2025
Q1
$13.7M Sell
683,616
-402,032
-37% -$8.86M 0.01% 641
2024
Q4
$23.6M Buy
1,085,648
+136,314
+14% +$3.51M 0.01% 541
2024
Q3
$25.9M Buy
949,334
+273,670
+41% +$7.62M 0.01% 522
2024
Q2
$17.6M Buy
675,664
+300,620
+80% +$7.23M 0.01% 591
2024
Q1
$11.3M Buy
+375,044
New +$8.15M 0.01% 671
2022
Q4
Sell
-413,612
Closed -$9.5M 2467
2022
Q3
$9.5M Buy
413,612
+225,876
+120% +$6.18M ﹤0.01% 836
2022
Q2
$3.57M Buy
187,736
+68,066
+57% +$1.68M ﹤0.01% 916
2022
Q1
$5.53M Buy
119,670
+110,173
+1,160% +$6.02M ﹤0.01% 994
2021
Q4
$672K Sell
9,497
-27,778
-75% -$2.79M ﹤0.01% 1711
2021
Q3
$4.34M Buy
37,275
+30,109
+420% +$3.51M ﹤0.01% 1088
2021
Q2
$1.12M Sell
7,166
-6,741
-48% -$1.24M ﹤0.01% 1311
2021
Q1
$2.63M Buy
+13,907
New +$2.34M ﹤0.01% 1137

Other funds holding DNTH